HEMOHIM Complex Extract Plus with Angelica Radix is a product made from Angelica Radix,

Cnidium officinale, and Paeonia japonica cultivated in Korea. It was developed through the
technology of the food bio-technology team of Korea Atomic Energy Research Institute.
HemoHIM Development
 Korea Atomic Energy Research Institute (KAERI) Food Engineering Team
 Research for functional food to increase bio-defense for radiation handlers - Joint research
between KAERI Biological Food Engineering Team and Atomic Energy Hospital
 Development of a health product called �gHemoHIM�h.
 Established Sun Biotech Co., Ltd (The first research institute company in Dae Duk Innopolis),
approved by Ministry of Education, Science and Technology. - Sun Biotech Co., Ltd. has been
established by joint venture between Kolmar Korea (Capital) and KAERI (Technology).

KAERI
Kolmar Korea
 Approved by the KFDA as an individual approval type health functional food.
 USA FDA approved
PDF,

�� Patent Registered 5 in Korea / 3 in oversea.(USA,EU,JAPAN)

 Herbal composition for improving anticancer activity, immune response and hematopoiesis of
the body, and protecting the body from oxidative damage, and the method of preparing the same
(USA:US6964785)
 Herbal composition comprising angelica gigantis, cnidium officinale and paeonia japonica
(EU:EP1466608B1)

�� IAEA 51st General Conference (2007 in Vienna)

The following documents have been described on the website of the IAEA.
 Development of Functional Foods for Body Protection Using Radiation ,2007
 Development of special medical foods and botanical drugs using HemoHIM for cancer
patients during radiation therapy ,2010
 Protection of mouse hematopoietic stem cells by a preparation of herb mixture (hemoHIM)
against whole body irradiation ,2002
 Radioprotective effects of a preparation (HemoHIM) of herb mixture on self-renewal tissues
and immune system in mice ,2004
 Protective effects of a preparation(hemoHIM) of herb mixture on self-renewal tissues and
immune system in whole body irradiated mice ,2002
 Human study of the herbal preparation(HemoHIM) on enhancement of immune and
hematopoietic functions ,2006
 Radioprotective effects of a preparation (HemoHIM) of a herb mixture ,2004
 Clinical evaluation of immune-promoting functions of the developed product (HemoHIM)
,2007
 Investigation on the effect of developed product and new food for radiation-induced skin
damage ,2007
 Practical use of herb mixture preparations as functional foods for hemato-immunomodulation
and cancer therapy assistance ,2006
 Studies on the protection effects of functional foods for skin immune system from radiation
damage ,2007
 In vivo evaluation on the effects of HemoHIM in promoting anticancer activities and reducing
the side-effects of anticancer drugs ,2009
 Evaluation on biosafety in long-term administration , teratogenicity and local toxicity of
developed product ,2006
 Clinical evaluation of developed product for recovery of immune system in the treatment of
cancer patients ,2006
 Characterization of active polysaccharides of HemoHIM ,2007
 Development of Functional Foods and Advanced Technology for Radioprotection ,2003
 In vivo evaluation on organ degeneration using radiation technology ,2010
 Development of advanced technology for stable support of Korean style space foods by the
collaboration with an industry ,2007
 Development of Modulators Against Degenerative Aging Using Radiation Fusion
Technology ,2010
 The technological innovation case of the KAERI ,2008
 A Study on the Nuclear Technology Policy ,2008
 Management and Development of the RT Research Facilities and Infrastructures ,2009
 Global Dynamics and International Cooperation Needs of RT Development and Utilization
for the Establishment of the Northeast Asia RT Hub in Korea ,2005
 Planning and Programming of Education and Training Courses on the Radiation Fusion
Technologies for Next Generations ,2009
 Foreign market development for Nuclear Power Plant Technology and Component ,2010
 Development of Radiation Fusion Biotechnology ,2010
�� Scholar

 Screening of anti-obesity agent from herbal mixtures.

PMID:22447026
 HemoHIM ameliorates the persistent down-regulation of Th1-like immune responses in
fractionated ��-irradiated mice by modulating the IL-12p70-STAT4 signaling pathway.
PMID:22439601
 HemoHIM enhances the therapeutic efficacy of ionizing radiation treatment in tumor-bearing
mice.
PMID:20136435
 Protective effect of an herbal preparation (HemoHIM) on radiation-induced intestinal injury in
mice.
PMID:20041793
 HemoHIM improves ovarian morphology and decreases expression of nerve growth factor in
rats with steroid-induced polycystic ovaries.
PMID:20041792
 Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing
mice.
PMID:19292900
 Restoration of the immune functions in aged mice by supplementation with a new herbal
composition, HemoHIM.
PMID:17705143
 Antiinflammatory activity of an herbal preparation (HemoHIM) in rats.
 PMID:17486680

Journal of MEDICAL FOOD BMC Cancer World Wide Science

Sunbiotech.Co.,Ltd
1310, Gwanpyeong-dong Yuseong-gu Daejeon, 305509 Korea
(PHONE) +82-42-671-2400 (FAX) +82-42-671-2401